Journal of Kermanshah University of Medical Sciences
Peer-reviewed Medical Quarterly
Outline
Determination of Rifampin and Isoniazid resistant mycobacterium tuberculosis in Kermanshah (2006-2008)
Authors
Abstract
Tuberculosis is one of the most important infectious diseases and a major cause of morbidity and mortality in developing countries. Multi drug resistant tuberculosis is a new threat, which can result in a high case fatality rate. This study was conducted to define the incidence of multidrug resistant tuberculosis in Kermanshah. Antibiogram was performed on PCR-confirmed isolates of mycobacterium tuberculosis by using the proportion method. Eight cases (57.1%) showed resistance to 1µg/ml Isoniazid. Resistance to Rifampicin was identified in 46.2% of cases. This study showed a high rate of single drug and multidrug resistance. We recommend antibiogram for all cases of tuberculosis.
References
- 1.The references of this article is available on PDF.
Copyright
© 2011, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Similar Articles
Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran
Habibnia S, Zaker S, Nasiri MJ, Doustdar F, Ghalavand Z, et al. Prevalence of Multidrug-Resistant Tuberculosis: A Six-Year Single-Center Retrospective Study in Tehran, Iran. Arch Clin Infect Dis. 2019;14(5):e82828. doi: https://doi.org/10.5812/archcid.82828
Tuberculosis and drug resistance in Iran
Sharifi-Mood B, Alavi-Naini R, Metanat M. Tuberculosis and drug resistance in Iran. Zahedan J Res Med Sci. 2010;12(3):e94292. doi:
Molecular Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Isolates from Lorestan Province, Iran from 2014 to 2017
Heidary F, Esmaeil Lashgarian H, Karkhane M, Najar Peerayeh S. Molecular Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Isolates from Lorestan Province, Iran from 2014 to 2017. Arch Clin Infect Dis. 2020;15(1):e81436. doi: https://doi.org/10.5812/archcid.81436
Evaluating the Frequency of Resistance to Pyrazinamide Among Drug-resistant Strains of Mycobacterium tuberculosis in Isfahan, Iran
Nasr-Esfahani B, Moghim S, Salehi M, Keikha M. Evaluating the Frequency of Resistance to Pyrazinamide Among Drug-resistant Strains of Mycobacterium tuberculosis in Isfahan, Iran. Arch Clin Infect Dis. 2021;16(2):e101092. doi: https://doi.org/10.5812/archcid.101092
Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan
Honarvar B, Moghadami M, Emami A, Behbahani AB, Taheri M, et al. Mycobacterium Strain and Type of Resistance in Pulmonary Tuberculosis Patients: A Missed Link in Iran’s National Tuberculosis Plan. Shiraz E-Med J. 2015;16(7):e59880. doi: https://doi.org/10.17795/semj27748
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 0
Last Update: 0 months ago
- Scopus by Title (Ref): 1
Last Update: 0 months ago
- CrossRef: 0
Last Update: 1 day ago